16 Amici Support Sanofi In High Court Genus Patent Claims Enablement Row

Mealey's (February 17, 2023, 7:55 AM EST) -- WASHINGTON, D.C. — Fellow pharmaceutical firms, professors and intellectual property organizations are among those that filed amicus curiae briefs in the U.S. Supreme Court supporting Sanofi in its dispute with Amgen Inc. over the proper enablement standard for patents that encompass genus claims....